Brockway Drug is the health system’s second retail compounding pharmacy.
Penn Highlands COO Mark Norman told the publication the health system targets drugstores for acquisition that are close to Penn Highlands physician offices and other healthcare facilities as a convenience for patients.
“It’s all about having a nice continuum of care. In today’s environment, you can’t just be a hospital,” Mr. Norman said.
Details of the transaction were not disclosed, according to The Bradford Era.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
